Blog
RSS FeedPosted by Michael Wonder on 22 Mar 2019
Ontario may lift ban preventing major pharmacies from selling private-label generic drugs
21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...
Posted by Michael Wonder on 20 Mar 2019
Unprecedented drug shortage linked to Brexit, NHS bosses say
20 March 2019 - Hospitals across England are experiencing medicine shortages due to "stockpiling and price pressure as the Brexit ...
Posted by Michael Wonder on 20 Mar 2019
Senate bill endorses Azar's call to allow drug imports
20 March 2019 - Bipartisan support for a Senate bill that seeks to allow drug importation to boost competition dovetails ...
Posted by Michael Wonder on 18 Mar 2019
Brexit - implications for therapeutic goods in Australia
18 March 2019 - In the event of a 'no deal' exit of the United Kingdom from the European Union, ...
Posted by Michael Wonder on 13 Mar 2019
Pharma urges politicians to stop no-deal Brexit in today’s vote
13 March 2019 - Pharma has urged politicians to reject a no-deal Brexit in today’s crunch vote, reiterating warnings that ...
Posted by Michael Wonder on 08 Mar 2019
Continued support for Australia’s community pharmacies
8 March 2019 - The Australian Government has announced key measures to support the delivery of medicines and important patient services ...
Posted by Michael Wonder on 15 Feb 2019
EU, America and China will all get new medicines ahead of Britain after Brexit, drug company boss warns
14 February 2019 - David Meek, the CEO of Ipsen, warns Britain leaving the European Union has seen the country fall ...
Posted by Michael Wonder on 13 Feb 2019
Statement from FDA Commissioner on new programs to promote the adoption of innovations in drug manufacturing that can improve quality and lower drug costs
13 February 2019 - Ensuring the safety of our nation’s drug supply is a cornerstone of our consumer protection mission. ...
Posted by Michael Wonder on 12 Feb 2019
Statement from FDA Commissioner on ongoing efforts to stop the spread of illicit opioids, further secure the U.S. drug supply chain and forcefully confront opioid epidemic
12 February 2019 - The opioid epidemic continues to be one of the greatest challenges facing this nation and the FDA. ...
Posted by Michael Wonder on 08 Feb 2019
FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain through innovations that improve tracking and tracing of medicines
7 February 2019 - A key element of the U.S. FDA’s mission is focused on helping to ensure that all ...
Posted by Michael Wonder on 07 Feb 2019
Diabetics in Britain worry a no-deal Brexit could put their lives at risk
6 February 2019 - Neil Macdougall has had Type 1 diabetes almost as long as he can remember. He wears ...
Posted by Michael Wonder on 29 Jan 2019
Novartis urges government to ‘minimise disruption’ in no-deal Brexit
28 January 2019 - Novartis has issued a statement expressing concern over the state of medicine supply to the UK, ...
Posted by Michael Wonder on 28 Jan 2019
Lords continue to call for clarity on ‘no-deal Brexit’ medicines access
28 January 2019 - As uncertainty remains on access to medicine in the event of a no-deal Brexit, Lords are ...
Posted by Michael Wonder on 22 Jan 2019
CVS, Walmart reach an agreement on a pharmacy contract after impasse
18 January 2019 - CVS Health and Walmart said the world's largest retailer would remain part of CVS's network for commercial ...
Posted by Michael Wonder on 21 Jan 2019
Contraceptive pill Levlen ED rationed as supply runs low across New Zealand
21 January 2019 - Popular contraceptive pill Levlen ED is being rationed amidst fears of a shortage. ...